Highly accomplished and strategic Chief Scientific Officer and biotech leader with over 20 years of experience translating advanced immunological science into real-world therapies. Specializes in cell and gene therapy, including CAR-T, CAR-NK, stem cell innovation, and immune-oncology. Proven track record of leading scientific programs from concept to IND, building and scaling R&D organizations, driving IP strategy, and forging high-impact external collaborations. Adept at the intersection of research, innovation, and translational development, delivering products to patients in need in oncology, autoimmune, and rare disease.More...